Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Development and evaluation of a FACS-based medium-throughput assay for HCV entry inhibitors.

Ziegler S, Kronenberger B, Albrecht BA, Kaul A, Gamer AL, Klein CD, Hartmann RW.

J Biomol Screen. 2009 Jul;14(6):620-6. doi: 10.1177/1087057109337161. Epub 2009 Jun 16.

PMID:
19531666
2.

Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: synthesis and structure optimization.

Holzer M, Ziegler S, Albrecht B, Kronenberger B, Kaul A, Bartenschlager R, Kattner L, Klein CD, Hartmann RW.

Molecules. 2008 May 7;13(5):1081-110.

3.

Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model.

Wangemann P, Itza EM, Albrecht B, Wu T, Jabba SV, Maganti RJ, Lee JH, Everett LA, Wall SM, Royaux IE, Green ED, Marcus DC.

BMC Med. 2004 Aug 20;2:30.

Supplemental Content

Loading ...
Support Center